We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SERPING1 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
364.3
Number of samples
349
Samples
Sample
Description
TPM
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
1332.3
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
1325.8
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1276.6
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
1131.3
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
1122.1
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
1112.4
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
1011.7
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
995.7
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
970.0
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
962.7
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
961.3
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
916.4
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
897.3
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
865.3
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
837.8
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
829.3
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
816.6
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
775.7
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
772.7
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
772.5
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
767.5
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
757.6
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
750.6
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
750.1
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
727.7
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
702.2
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
700.9
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
697.3
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
689.4
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
680.0
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
669.3
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
669.2
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
662.1
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
657.8
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
654.0
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
639.4
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
619.3
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
618.3
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
608.9
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
608.5
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
608.0
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
606.0
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
602.4
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
596.6
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
594.4
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
594.3
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
587.2
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
587.1
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
586.2
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
575.2
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
569.2
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
568.1
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
564.3
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
562.4
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
560.4
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
559.4
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
558.7
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
558.3
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
555.6
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
554.8
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
553.2
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
550.3
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
533.5
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
531.8
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
528.9
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
528.7
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
525.5
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
518.5
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
516.4
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
514.5
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
513.8
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
512.7
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
510.8
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
510.2
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
508.2
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
505.0
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
492.4
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
491.6
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
491.3
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
489.5
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
488.3
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
487.8
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
486.6
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
486.1
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
484.8
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
480.2
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
479.6
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
475.8
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
475.6
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
475.5
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
474.3
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
472.4
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
471.4
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
470.9
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
469.8
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
468.6
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
467.8
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
466.7
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
465.4
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
464.2
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
460.5
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
457.5
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
455.7
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
455.5
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
452.0
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
449.0
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
445.1
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
445.1
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
443.5
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
441.4
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
440.6
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
438.3
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
437.1
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
434.1
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
430.7
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
430.4
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
425.6
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
423.7
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
416.8
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
411.3
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
410.4
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
407.8
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
407.0
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
406.4
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
404.6
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
403.2
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
400.9
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
400.7
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
399.8
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
398.8
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
398.7
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
396.9
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
391.4
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
391.2
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
390.9
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
389.8
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
389.8
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
389.6
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
388.5
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
387.4
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
386.9
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
384.3
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
379.9
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
377.0
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
375.0
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
375.0
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
374.6
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
373.5
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
369.6
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
368.0
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
367.0
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
366.3
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
365.3
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
364.4
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
361.4
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
361.3
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
360.9
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
357.3
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
355.9
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
355.5
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
355.2
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
353.9
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
350.9
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
343.4
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
338.9
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
337.3
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
336.1
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
334.9
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
334.7
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
332.5
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
331.1
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
330.6
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
328.0
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
324.3
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
323.3
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
322.3
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
320.7
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
320.4
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
317.9
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
316.8
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
312.4
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
311.1
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
311.0
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
309.0
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
306.8
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
306.2
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
305.0
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
304.2
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
302.3
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
302.0
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
300.1
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
297.2
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
297.1
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
295.1
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
293.9
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
293.5
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
293.3
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
292.6
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
292.3
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
292.3
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
291.1
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
287.3
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
281.5
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
279.8
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
276.6
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
276.5
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
275.7
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
275.5
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
274.4
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
274.3
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
273.1
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
270.1
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
267.6
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
267.4
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
265.5
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
265.3
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
264.7
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
264.0
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
258.2
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
257.9
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
257.7
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
255.1
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
255.0
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
254.3
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
247.0
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
246.8
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
245.7
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
245.3
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
241.8
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
239.2
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
238.3
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
233.2
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
231.3
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
230.0
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
229.7
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
226.2
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
225.9
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
223.7
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
222.1
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
222.0
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
221.8
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
218.3
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
217.4
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
213.8
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
213.1
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
212.5
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
211.2
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
207.9
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
200.7
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
196.3
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
195.4
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
193.0
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
191.6
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
190.9
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
189.2
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
188.1
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
187.1
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
186.9
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
185.7
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
182.5
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
182.2
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
181.1
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
180.2
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
178.6
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
175.6
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
171.4
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
171.0
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
169.6
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
168.7
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
168.1
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
168.0
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
166.5
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
166.4
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
166.3
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
165.9
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
163.2
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
161.5
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
158.4
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
158.0
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
157.6
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
156.5
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
156.1
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
155.6
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
155.0
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
154.6
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
154.1
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
153.5
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
153.5
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
153.0
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
152.6
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
151.8
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
150.8
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
150.1
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
148.4
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
147.7
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
145.9
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
145.8
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
145.1
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
145.0
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
144.5
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
143.5
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
143.3
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
143.2
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
143.1
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
142.9
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
142.9
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
142.7
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
142.2
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
138.3
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
137.2
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
135.6
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
134.7
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
132.9
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
132.7
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
132.1
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
132.0
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
126.4
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
125.5
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
125.0
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
121.5
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
120.5
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
113.9
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
112.8
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
106.9
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
106.0
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
105.6
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
102.4
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
99.0
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
97.9
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
97.5
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
96.6
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
96.2
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
94.7
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
91.2
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
83.9
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
83.4
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
79.6
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
74.6
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
71.3
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
68.4
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
65.3
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
64.3
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
62.7
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
62.0
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
38.6
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
38.4
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
38.4
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
34.3
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SERPING1 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
230.6
Number of samples
81
Samples
Sample
Description
TPM
DO46402
0 years, female, NA, stage:III, dead, 511 days
674.6
DO46591
0 years, female, NA, stage:III, dead, 195 days
647.9
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
494.1
DO46398
0 years, female, NA, stage:III, alive, 437 days
487.6
DO46468
0 years, female, NA, stage:III, alive, 2776 days
460.3
DO46352
0 years, female, NA, stage:III, dead, 677 days
435.8
DO46376
0 years, female, NA, stage:III, dead, 1430 days
416.6
DO46404
0 years, female, NA, stage:III, dead, 690 days
402.5
DO46332
0 years, female, NA, stage:III, dead, 689 days
378.6
DO46443
0 years, female, NA, stage:III, dead, 2464 days
368.6
DO46453
0 years, female, NA, stage:III, dead, 3294 days
366.3
DO46378
0 years, female, NA, stage:III, alive, 843 days
339.5
DO46436
0 years, female, NA, stage:III, alive, 3193 days
337.0
DO46581
0 years, female, NA, stage:III, dead, 408 days
330.7
DO46327
0 years, female, NA, stage:III, dead, 184 days
330.5
DO46463
0 years, female, NA, stage:III, dead, 2451 days
323.7
DO46508
0 years, female, NA, stage:III, dead, 2101 days
323.1
DO46340
0 years, female, NA, stage:III, dead, 616 days
321.3
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
320.9
DO46354
0 years, female, NA, stage:III, dead, 843 days
313.2
DO46334
0 years, female, NA, stage:III, dead, 496 days
312.7
DO46348
0 years, female, NA, stage:IV, dead, 287 days
308.2
DO46346
0 years, female, NA, stage:III, dead, 1187 days
302.7
DO46350
0 years, female, NA, stage:III, dead, 886 days
302.6
DO46388
0 years, female, NA, stage:III, dead, 413 days
282.3
DO46448
0 years, female, NA, stage:III, dead, 654 days
280.5
DO46493
0 years, female, NA, stage:IV, alive, 839 days
277.7
DO46368
0 years, female, NA, stage:III, dead, 2879 days
271.6
DO46344
0 years, female, NA, stage:III, dead, 642 days
263.0
DO46412
0 years, female, NA, stage:III, dead, 597 days
252.6
DO46328
0 years, female, NA, stage:III, dead, 972 days
251.7
DO46366
0 years, female, NA, stage:III, dead, 2054 days
250.7
DO46396
0 years, female, NA, stage:III, dead, 583 days
250.2
DO46380
0 years, female, NA, stage:III, dead, 1423 days
247.6
DO46336
0 years, female, NA, stage:IV, dead, 664 days
245.6
DO46358
0 years, female, NA, stage:III, dead, 423 days
238.8
DO46338
0 years, female, NA, stage:III, dead, 596 days
233.7
DO46362
0 years, female, NA, stage:III, dead, 1639 days
229.6
DO46326
0 years, female, NA, stage:III, dead, 701 days
226.8
DO46331
0 years, female, NA, stage:III, dead, 612 days
207.6
DO46528
0 years, female, NA, stage:III, alive, 6139 days
200.8
DO46432
0 years, female, NA, stage:III, alive, 2218 days
200.0
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
198.9
DO46364
0 years, female, NA, stage:III, dead, 806 days
197.9
DO46560
0 years, female, NA, stage:IV, dead, 286 days
197.5
DO46576
0 years, female, NA, stage:III, alive, 133 days
192.4
DO46597
0 years, female, NA, stage:III, dead, 393 days
186.4
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
184.0
DO46386
0 years, female, NA, stage:III, dead, 1162 days
180.4
DO46356
0 years, female, NA, stage:III, dead, 911 days
173.9
DO46382
0 years, female, NA, stage:IV, dead, 311 days
168.4
DO46606
0 years, female, NA, stage:III, alive, 804 days
167.6
DO46374
0 years, female, NA, stage:III, dead, 1409 days
164.3
DO46571
0 years, female, NA, stage:III, dead, 243 days
161.1
DO46611
0 years, female, NA, stage:III, dead, 734 days
154.3
DO46392
0 years, female, NA, stage:III, dead, 628 days
154.3
DO46602
0 years, female, NA, stage:III, dead, 205 days
154.1
DO46372
0 years, female, NA, stage:III, dead, 1326 days
149.5
DO46400
0 years, female, NA, stage:III, dead, 719 days
148.4
DO46330
0 years, female, NA, stage:III, dead, 684 days
139.9
DO46568
0 years, female, NA, stage:III, dead, 320 days
134.7
DO46566
0 years, female, NA, stage:III, dead, 673 days
132.7
DO46342
0 years, female, NA, stage:III, dead, 1398 days
131.9
DO46551
0 years, female, NA, stage:III, dead, 1055 days
129.2
DO46325
0 years, female, NA, stage:III, dead, 477 days
126.8
DO46384
0 years, female, NA, stage:III, dead, 614 days
124.6
DO46408
0 years, female, NA, stage:III, dead, 489 days
115.3
DO46588
0 years, female, NA, stage:III, dead, 438 days
101.6
DO46538
0 years, female, NA, stage:III, dead, 1527 days
100.6
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
97.4
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
87.9
DO46329
0 years, female, NA, stage:III, dead, 1699 days
87.1
DO46546
0 years, female, NA, stage:III, dead, 1889 days
84.8
DO46333
0 years, female, NA, stage:III, dead, 359 days
83.3
DO46390
0 years, female, NA, stage:III, dead, 374 days
59.7
DO46533
0 years, female, NA, stage:III, alive, 3667 days
58.0
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
55.1
DO46586
0 years, female, NA, stage:III, dead, 1019 days
52.5
DO46518
0 years, female, NA, stage:III, alive, 2960 days
50.2
DO46561
0 years, female, NA, stage:III, dead, 195 days
43.4
DO46370
0 years, female, NA, stage:III, dead, 1727 days
39.5
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
1.6
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
1.5
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
1.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
1.2
a3a26070-fb84-406a-8280-d555e6_D2
Normal
1.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
1.0
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
1.0
a65d8e76-640f-4341-a561-afbb57_D2
Normal
1.0
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.9
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.9
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.8
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.7
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.6
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.6
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.6
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.6
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.6
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.5
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
0.5
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.5
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.5
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
0.5
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.5
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.5
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.4
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.4
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.3
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.3
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.3
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.2
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.2
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.1
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.1
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.1
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.1
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
0.1
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.1
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
0.0
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.0
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.0
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.1
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.1
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-0.1
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.1
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.1
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.1
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.1
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-0.1
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.1
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.2
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.2
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-0.2
15524912-685a-47ce-a824-567848_D2
Tumor
-0.2
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.3
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.3
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-0.3
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.3
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.3
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.3
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-0.3
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.3
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.3
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.3
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.3
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
-0.3
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.4
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.4
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.4
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.4
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-0.4
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-0.5
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.5
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.5
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.5
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.5
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.5
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.5
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.5
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.5
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.6
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.6
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-0.6
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-0.6
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.6
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
-0.6
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.6
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.6
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-0.6
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.7
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.7
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.7
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.7
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-0.7
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-0.8
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-0.8
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-0.8
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.8
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.8
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-0.9
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.9
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.9
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-0.9
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-0.9
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.9
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.9
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
-1.0
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-1.0
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-1.2
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.